TerrAscend Commences Cultivation of Medical Cannabis

/NOT FOR DISSEMINATION IN THE UNITED STATES OR TO UNITED STATES NEWSWIRE SERVICES/

TORONTO, August 29, 2017 – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”), is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. (“Solace Health”), has commenced cultivation activities at its headquarters in Mississauga, Ontario. The experienced team at Solace Health will begin cultivation by planting rooted starting materials, with an anticipated flowering cycle of approximately eight weeks. Solace Health will initially cultivate a variety of cannabis strains sought by Canadian patients, including offerings with varying THC and CBD concentrations and genetic subtypes. “We’re excited to begin our cultivation efforts and provide Canada’s medical cannabis community with a truly high quality, premium product,” noted TerrAscend’s President & Chief Executive Officer, Basem Hanna. “Planting our first crop is monumental for TerrAscend and Solace Health as it enables us to diligently move forward and obtain further licenses, including a sales license, through Health Canada.” Solace Health’s cultivation and facility teams have built a state of the art, indoor hydroponic growing environment that will enable it to produce high quality, pesticide-free medical cannabis for Canadian patients under the Access to Cannabis for Medical Purposes Regulations. To achieve their strict quality standards, the cultivation team has built a modular, purpose-built facility that provides comprehensive environmental controls and pest management systems.